PALATIN TECHNOLOGIES, INC. Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net
PALATIN TECHNOLOGIES, INC. (PTN) reported Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net of $7.56 million for the 12-month period ending 2021-06-30, per its 10-K filed 2021-09-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet · last filed 2021-09-28
- PALATIN TECHNOLOGIES, INC. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2019-06-30 was -$4.35K.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2019-03-31 was -$8.70K.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2018-12-31 was -$17.30K.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2018-09-30 was -$25.65K.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2021 was $7.56M.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2020 was $0.00.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2019 was -$55.99K.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2018 was -$189.56K.
| Period end | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 12 month |
|---|---|---|---|---|
| 2021-06-30 | $7.56M 10-K · filed 2021-09-28 | |||
| 2020-06-30 | $0.00 10-K · filed 2021-09-28 | |||
| 2019-06-30 | -$4.35K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25 | -$13.04K derived: sum of 2 quarters · filed 2020-09-25 | -$30.34K derived: sum of 3 quarters · filed 2020-09-25 | -$55.99K 10-K · filed 2020-09-25 |
| 2019-03-31 | -$8.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-09 | -$25.99K derived: sum of 2 quarters · filed 2019-05-09 | -$51.64K 10-Q · filed 2019-05-09 | -$85.99K derived: sum of 4 quarters · filed 2020-09-25 |
| 2018-12-31 | -$17.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-11 | -$42.95K 10-Q · filed 2019-02-11 | -$77.30K derived: sum of 3 quarters · filed 2020-09-25 | -$120.34K derived: sum of 4 quarters · filed 2020-09-25 |
| 2018-09-30 | -$25.65K 10-Q · filed 2018-11-09 | -$60.00K derived: sum of 2 quarters · filed 2020-09-25 | -$103.04K derived: sum of 3 quarters · filed 2020-09-25 | -$154.78K derived: sum of 4 quarters · filed 2020-09-25 |
| 2018-06-30 | -$34.35K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25 | -$77.39K derived: sum of 2 quarters · filed 2020-09-25 | -$129.13K derived: sum of 3 quarters · filed 2020-09-25 | -$189.56K 10-K · filed 2020-09-25 |
| 2018-03-31 | -$43.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-09 | -$94.78K derived: sum of 2 quarters · filed 2019-05-09 | -$155.22K 10-Q · filed 2019-05-09 | -$224.35K derived: sum of 4 quarters · filed 2019-09-12 |
| 2017-12-31 | -$51.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-11 | -$112.17K 10-Q · filed 2019-02-11 | -$181.30K derived: sum of 3 quarters · filed 2019-09-12 | -$258.65K derived: sum of 4 quarters · filed 2019-09-12 |
| 2017-09-30 | -$60.44K 10-Q · filed 2018-11-09 | -$129.56K derived: sum of 2 quarters · filed 2019-09-12 | -$206.91K derived: sum of 3 quarters · filed 2019-09-12 | -$289.08K derived: sum of 4 quarters · filed 2019-09-12 |
| 2017-06-30 | -$69.13K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-12 | -$146.47K derived: sum of 2 quarters · filed 2019-09-12 | -$228.65K derived: sum of 3 quarters · filed 2019-09-12 | -$314.83K 10-K · filed 2019-09-12 |
| 2017-03-31 | -$77.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | -$159.52K derived: sum of 2 quarters · filed 2018-05-14 | -$245.70K 10-Q · filed 2018-05-14 | -$332.66K derived: sum of 4 quarters · filed 2018-09-13 |
| 2016-12-31 | -$82.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-12 | -$168.36K 10-Q · filed 2018-02-12 | -$255.31K derived: sum of 3 quarters · filed 2018-09-13 | -$342.27K derived: sum of 4 quarters · filed 2018-09-13 |
| 2016-09-30 | -$86.18K 10-Q · filed 2017-11-13 | -$173.14K derived: sum of 2 quarters · filed 2018-09-13 | -$260.10K derived: sum of 3 quarters · filed 2018-09-13 | -$347.05K derived: sum of 4 quarters · filed 2018-09-13 |
| 2016-06-30 | -$86.96K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-13 | -$173.91K derived: sum of 2 quarters · filed 2018-09-13 | -$260.87K derived: sum of 3 quarters · filed 2018-09-13 | -$347.83K 10-K · filed 2018-09-13 |
| 2016-03-31 | -$86.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | -$173.91K derived: sum of 2 quarters · filed 2017-05-15 | -$260.87K 10-Q · filed 2017-05-15 | -$352.17K derived: sum of 4 quarters · filed 2017-09-25 |
| 2015-12-31 | -$86.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10 | -$173.91K 10-Q · filed 2017-02-10 | -$265.22K derived: sum of 3 quarters · filed 2017-09-25 | -$265.22K derived: sum of 4 quarters · filed 2017-09-25 |
| 2015-09-30 | -$86.96K 10-Q · filed 2016-11-14 | -$178.26K derived: sum of 2 quarters · filed 2017-09-25 | -$178.26K derived: sum of 3 quarters · filed 2017-09-25 | |
| 2015-06-30 | -$91.30K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | -$91.30K derived: sum of 2 quarters · filed 2017-09-25 | -$91.30K 10-K · filed 2017-09-25 | |
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-16 | $0.00 10-Q · filed 2016-05-16 | ||
| 2014-12-31 | $0.00 10-Q · filed 2016-02-12 | |||
| 2014-06-30 | $0.00 10-K · filed 2016-09-19 | |||
| 2013-06-30 | $0.00 10-K · filed 2015-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |